Listar Bordeaux Population Health Research Center (BPH) - UMR 1219 por autor "DALLONGEVILLE, J."
Mostrando ítems 1-6 de 6
-
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
FAUCHIER, L.; BLIN, Patrick; SACHER, F. ...(EP-Europace. vol. 22, n° 2, pp. 205-215, 2020)Article de revue -
Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
MOORE, Nicholas; FAUCHIER, L.; SACHER, F. ...
(European Heart Journal. vol. 39, pp. 1014-1014, 2018-08)Article de revue -
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
BLIN, Patrick; FAUCHIER, L.; DUREAU-POURNIN, C. ...(Stroke. vol. 50, n° 9, pp. 2469-2476, 2019)Article de revueLibre acceso -
Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction
GRIMALDI-BENSOUDA, L.; DANCHIN, N.; DALLONGEVILLE, J. ...(Heart (British Cardiac Society). vol. 104, n° 19, pp. 1583-1592, 2018-10)Article de revue -
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
BLIN, Patrick; DUREAU-POURNIN, C.; BENICHOU, Jacques ...(Atherosclerosis. vol. 281, pp. 98-106, 2019)Article de revue -
Determinants and outcome of multiple and early recurrent cervical artery dissections
COMPTER, A.; SCHILLING, S.; VAINEAU, C. J. ...(Neurology. vol. 91, n° 8, pp. e769-e780, 2018-08-21)Article de revue